Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 496 entries
View as:

A Study of Vismodegib in Patients With Advanced Solid Malignancies Including Hepatocellular Carcinoma With Varying Degrees of Renal or Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT01546519 Org: User:
Start: 03/31/12 End: 04/30/14 Due: 04/30/15

A Study to Assess the Relative Bioavailability And Food Effect of a Tablet Formulation of GDC-0276 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02856152 Org: User:
Start: 06/30/16 End: 11/30/16 Due: 11/30/17

A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT00282308 Org: User:
Start: 01/23/06 End: 05/28/12 Due: 05/28/13

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT06850922 Org: User:
Start: 06/22/22 End: 04/30/27 Due: 04/30/28

A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00747734 Org: User:
Start: 09/30/08 End: - Due: -

A Study to Evaluate the Effect of Injection Site on PK of Astegolimab in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06462118 Org: User:
Start: 06/17/24 End: 10/22/24 Due: 10/22/25

A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone

Phase: N/A Priority: Normal
NCT ID: NCT00097552 Org: User:
Start: 05/31/97 End: 07/31/10 Due: 07/31/11

Evaluation of the Relative Bioavailability and Food Effect of GDC-9545 in Healthy Females of Non-Childbearing Potential

Phase: N/A Priority: Normal
NCT ID: NCT04274075 Org: User:
Start: 03/06/20 End: 04/16/20 Due: 04/16/21

A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection

Phase: N/A Priority: Normal
NCT ID: NCT02293863 Org: User:
Start: 01/14/15 End: 05/23/17 Due: 05/23/18

A Study of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT00541749 Org: User:
Start: 02/28/07 End: - Due: -

A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

Phase: N/A Priority: Normal
NCT ID: NCT00096967 Org: User:
Start: 10/31/02 End: 07/31/04 Due: 07/31/05

A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib

Phase: N/A Priority: Normal
NCT ID: NCT00453362 Org: User:
Start: 12/31/06 End: 04/23/10 Due: 04/23/11

A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib)

Phase: N/A Priority: Normal
NCT ID: NCT00854308 Org: User:
Start: 04/30/09 End: 01/31/12 Due: 01/31/13

A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic Atrophy

Phase: N/A Priority: Normal
NCT ID: NCT01229215 Org: User:
Start: 02/28/11 End: 04/30/13 Due: 04/30/14

A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01522664 Org: User:
Start: 03/31/12 End: 06/30/15 Due: 06/30/16

A Study of Obinutuzumab (GA101; RO5072759) in Combination With Chemotherapy in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GALTON)

Phase: N/A Priority: Normal
NCT ID: NCT01300247 Org: User:
Start: 05/31/11 End: 12/31/15 Due: 12/31/16

Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01356173 Org: User:
Start: 06/30/11 End: 12/31/12 Due: 12/31/13

A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01633970 Org: User:
Start: 07/11/12 End: 02/26/20 Due: 02/26/21

A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)

Phase: N/A Priority: Normal
NCT ID: NCT01343966 Org: User:
Start: 04/30/11 End: 02/28/14 Due: 02/28/15

A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)

Phase: N/A Priority: Normal
NCT ID: NCT01163747 Org: User:
Start: 09/30/10 End: 06/30/12 Due: 06/30/13

A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03332797 Org: User:
Start: 11/24/17 End: 06/30/26 Due: 06/30/27

A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06619587 Org: User:
Start: 11/14/24 End: 05/31/28 Due: 05/31/29

A Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04302025 Org: User:
Start: 11/06/20 End: 03/06/29 Due: 03/06/30

Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05954871 Org: User:
Start: 01/08/24 End: 12/31/26 Due: 12/31/27

A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01469793 Org: User:
Start: 11/30/11 End: 12/31/15 Due: 12/31/16